Methuen, MA, United States of America

Qian Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qian Chen. Retrieved from https://idiyas.com/inventor/qian-chen-90v8y57w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qian Chen: Innovator in Autoimmune Disorder Treatments

Introduction

Qian Chen is a notable inventor based in Methuen, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune disorders. His innovative work has led to the development of valuable compounds that can potentially improve patient outcomes.

Latest Patents

Qian Chen holds 1 patent for his invention related to hydantoin compounds. This invention focuses on the use of hydantoin compounds that are useful for treating or preventing autoimmune disorders. The patent also encompasses various compositions and their applications, showcasing the potential impact of his work in the medical field.

Career Highlights

Qian Chen is currently employed at Eisai R&D Management Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to advancements in pharmaceutical science. His expertise and dedication have positioned him as a key figure in his field.

Collaborations

Throughout his career, Qian Chen has collaborated with talented professionals, including Brian M Gallagher, Jr. and Eric Carlson. These collaborations have fostered an environment of innovation and have enhanced the quality of research conducted at Eisai R&D Management Co., Ltd.

Conclusion

Qian Chen's work in developing hydantoin compounds represents a significant advancement in the treatment of autoimmune disorders. His contributions to the field highlight the importance of innovation in medicine and the potential for improved therapies for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…